OPS
EBS icon

Orion Portfolio Solutions’s Emergent Biosolutions EBS Stock Holding History

Orion Portfolio Solutions’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-133
Closed -$11K – 859
2020
Q2 		$11K Buy
133
+38
+40% +$2.83K ﹤0.01% 1159
2020
Q1 		$5K Buy
95
+69
+265% +$3.98K ﹤0.01% 1281
2019
Q4 		$1K Buy
+26
New +$1.41K ﹤0.01% 1641

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Orion Portfolio Solutions's EBS Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of Emergent Biosolutions (EBS) in Q3 2020, closing a stake of 133 shares — an estimated $11K sold.

Orion Portfolio Solutions first reported a position in EBS in Q4 2019 and held it in 3 quarters. The position peaked at $11K in Q2 2020. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining Emergent Biosolutions position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 133 Emergent Biosolutions shares in Q3 2020, an estimated $11K.
  • Orion Portfolio Solutions first reported a position in Emergent Biosolutions in Q4 2019 and held it in 3 quarters.
  • Orion Portfolio Solutions's Emergent Biosolutions position peaked at $11K in Q2 2020.
  • 358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.